Emergent BioSolutions (EBS) Gross Profit Growth (3y) (2014 - 2026)
Emergent BioSolutions (EBS) Gross Profit Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 7.62% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 4.71% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 12.55% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 76.85% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 24.80% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 0.95% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -35.83% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 44.16% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 37.26% |
| 10 | Emergent BioSolutions | 427.92 Mn | 266.42 Mn | 84.10 Mn | 94.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.67% |
| Dec 31, 2025 | -26.84% |
| Sep 30, 2025 | -2.09% |
| Jun 30, 2025 | -23.27% |
| Mar 31, 2025 | -23.94% |
| Dec 31, 2024 | -49.28% |
| Sep 30, 2024 | -15.64% |
| Mar 31, 2024 | -22.16% |
| Dec 31, 2023 | -35.03% |
| Sep 30, 2023 | -35.94% |
| Jun 30, 2023 | -17.77% |
| Mar 31, 2023 | -53.80% |
| Dec 31, 2022 | -35.24% |
| Sep 30, 2022 | -8.78% |
| Jun 30, 2022 | 4.78% |
| Mar 31, 2022 | 45.43% |
| Dec 31, 2021 | 55.22% |
| Sep 30, 2021 | 39.79% |
| Jun 30, 2021 | 29.97% |
| Mar 31, 2021 | 73.27% |